Stay updated with breaking news from Synchron Switch. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The funding will accelerate development of Synchron’s first platform product (Synchron SwitchTM BCI), and launch a pivotal clinical trial.
Synchron announced today that it raised an oversubscribed $75 million Series C financing round for its brain-computer interface (BCI).
Disease detection company Cardiosense, sustainable pill bottle maker Cabinet Health, testing company LumiraDx and physician engagement platform KeyOps also garner investments.
Disease detection company Cardiosense, sustainable pill bottle maker Cabinet Health, testing company LumiraDx and physician engagement platform KeyOps also garner investments.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!